GPT and metabolic dysfunction-associated steatotic liver disease: In an RCT in which 109 children with NAFLD confirmed by biopsy participated and were given 2000 IU/day of vitamin D or a placebo for six months, the treated group reduced hepatic steatosis, lobular inflammation, AST, and ALT levels and improved lipid profile and IR [66].